findmyKOL

Richard Spaide, MD

Enriched profile

Clinical Associate Professor, Department of Ophthalmology, NYU Grossman School of Medicine · Vitreous Retina Macula Consultants of New York

ORCIDNPI
Region🇺🇸 New York, NY · Northeast · United StatesSpecialtyOphthalmologyFocusRetinal Diseases and Treatments+4
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2021Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Richard Spaide is Clinical Associate Professor, Department of Ophthalmology, NYU Grossman School of Medicine at Vitreous Retina Macula Consultants of New York. OpenAlex indexes 566 publications with 46,557 citations (h-index 109); ClinicalTrials.gov lists 5 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Ophthalmology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Richard Spaide, MD, is Clinical Associate Professor, Department of Ophthalmology, NYU Grossman School of Medicine at Vitreous Retina Macula Consultants of New York, P.C.. The public record shows 566 publications with 46,557 citations (h-index 109), centered on Retinal Diseases and Treatments, Ocular Diseases and Behçet’s Syndrome, Retinal and Optic Conditions. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 22 companies.

  • Top research focus: Retinal Diseases and Treatments
  • 5 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 22 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Macular Degeneration (AMD)1 trialRetinal Vein Occlusion1 trialCentral Serous Chorioretinopathy1 trialChoroidal Neovascularization1 trial

Research focus

OpenAlex concept fingerprint
Retinal Diseases and TreatmentsOcular Diseases and Behçet’s SyndromeRetinal and Optic ConditionsRetinal and Macular SurgeryRetinal Imaging and Analysis

Drugs & molecules

across trials, industry payments and publications
Vabysmogeneric · FaricimabClinical trialsIndustry payments13PublicationsLucentisgeneric · RanibizumabClinical trialsIndustry payments7PublicationsEyleageneric · AfliberceptClinical trialsIndustry payments5Publications

Works with

trial sponsors and companies reporting payments
Topcon Medical Systems, Inc.Clinical trialsIndustry payments25Topcon Healthcare, Inc.Clinical trialsIndustry payments13Merck Sharp & Dohme LLCClinical trialsIndustry payments12

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
566publications

Distinct works indexed by OpenAlex, matched via ORCID.

46,557citations

Total citations across indexed works.

109h-index

Hirsch index (OpenAlex). i10-index 331.

Clinical & industry

trials, payments and federal funding
5clinical trials

Investigator role on registered studies.

View trials
22companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

22 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    99.3%
    Antineovascularisation agents98.6%
    Faricimab-svoa100%
    Part B, office-administered173 patients
    Vascular Endothelial Growth Factor Inhibitor0.3%
    Ranibizumab100%
    Part B, office-administered14 patients
  • Cancer & immunology

    0.6%
    Vascular Endothelial Growth Factor Inhibitor0.6%
    Aflibercept100%
    Part B, office-administered57 patients
  • Cardiovascular

    0%
    Beta blocker0%
    Timolol Maleate100%
    Part D<11 patients
1 more therapeutic area behind the reveal.Reveal →
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Network

Updated 27 Aug 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/richard-spaide-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • LinkedIn

    linkedin.com/in/richard-spaide-b672011b7

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com

Mentions by others

where others cite or feature them
  • Other

    retinahistory.asrs.org/video-interviews/richard-spaide

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →retinahistory.asrs.org
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Board Certified

    American Board of Ophthalmology

    1987
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org
  • MD

    Sidney Kimmel Medical College at Thomas Jefferson University (formerly Jefferson Medical College)

    1981
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org
  • BA/BS

    Muhlenberg College (undergraduate)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vrmny.com
  • Ophthalmology Residency

    St. Vincent's Hospital and Medical Center, New York

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vrmny.com
  • Vitreoretinal Surgical Fellowship

    Manhattan Eye, Ear & Throat Hospital

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vrmny.com

Editorial & leadership roles

journal and society appointments
  • Past Executive Editor

    American Journal of Ophthalmology

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →vrmny.com
  • Associate Editor

    Retina (journal)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →vrmny.com

Awards & honors

honors on the public record
3 more awards behind the reveal.Reveal →

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.